Abiomed Inc (ABMD.O)

ABMD.O on Consolidated Issue listed on NASDAQ Global Market

8.16USD
18 Dec 2009
Price Change (% chg)

$0.06 (+0.74%)
Prev Close
$8.10
Open
$8.18
Day's High
$8.28
Day's Low
$8.07
Volume
352,828
Avg. Vol
252,665
52-wk High
$17.31
52-wk Low
$4.67

ABMD.O

Chart for ABMD.O

About

Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients. The Company’s products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. Its products can be used... (more)

Overall

Beta: 0.93
Market Cap (Mil.): $303.63
Shares Outstanding (Mil.): 37.49
Annual Dividend: 0.00
Yield (%): NA

Financials

  ABMD.O Industry Sector
P/E (TTM): -- 5.84 4.61
EPS (TTM): 26.20 -- --
ROI: -25.35 1.13 2.83
ROE: -26.18 1.67 3.59
view overview for:

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1858 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1726 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1624 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1536 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1501 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1243 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1205 GMT

RTRS

 Following is a summary of research actions on non-S&P 500 companies reported

06 Feb 2009

UPDATE 1-Abiomed Q3 loss narrows; sees FY rev at low end

Feb 5 (Reuters) - Heart pump maker Abiomed Inc reported a narrower quarter loss mainly on strong revenue from its Impella catheter pumps, and forecast fiscal 2009 revenue at the lower end of its previous outlook.

05 Feb 2009

US RESEARCH SUMMARY-Non-S&P 500 Nov 11 1650 GMT

Following is a summary of research actions on non-S&P 500

11 Nov 2008

INTERVIEW-Abiomed eyes $2 bln opportunity in heart pumps

* Sees rapid market adoption of device since June launch

08 Oct 2008

  Earnings  vs    Estimates

view overview for: